Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF, 202K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by LeBrasseur, N. Search for Related Content PubMed Articles by LeBrasseur, N. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/2002/8/384 $5.00
The Journal of Cell Biology, Volume 158, Number 3, August 5, 2002 384-384

A molecule with a sense of timing

c-Fos (green) is more stable (top to bottom) in PDGF-treated cells. Blenis/Macmillan

Duration of kinase signaling determines how a cell responds to external cues like growth factors. But how a cell measures signaling time has been a mystery. Now, Leon Murphy, John Blenis (Harvard Medical School, Boston, MA), and colleagues have found that immediate early gene (IEG) products have a sensor mechanism that makes these distinctions. Their findings may provide a target for cancer treatment drugs.

Growth factors PDGF and EGF elicit different responses in fibroblasts, with only PDGF inducing cells to enter S-phase. The group found that EGF transiently activated ERK MAP kinases, whereas PDGF stimulated prolonged activation. The IEG product c-Fos is known to be transcribed with similar kinetics in response to either growth factor, but c-Fos was only phosphorylated when ERK activity was sustained. This not only stabilized c-Fos, but also primed it for further phosphorylation by revealing a DEF domain, an ERK-docking motif. Without secondary phosphorylation, c-Fos was less able to promote cellular transformation.

"Since several other IEGs also have DEF domains," says Blenis, "this group of IEGs may act as molecular sensors in many processes," including neuronal differentiation and the generation of an immune response. Blenis and Murphy hope it will be possible to antagonize these sensors to block specifically ERK-regulated proliferation, such as that seen in Ras-induced cancers, thus possibly avoiding toxic side effects caused by disturbing ERK's other homeostatic cellular functions.

Reference:

Murphy, L., et al. 2002. Nat. Cell Biol. 10.1038/ncb822.

Nicole LeBrasseur

lebrasn{at}rockefeller.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF, 202K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by LeBrasseur, N. Search for Related Content PubMed Articles by LeBrasseur, N. Social Bookmarking                            What's this?